These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2014-001081-99||A clinical trial to document safety and radiological disease activity in patients with relapsing-remitting multiple sclerosis treated with autologous CD4+ cells, stimulated and expanded ex vivo by a m...||2016-03-02||not-yet-due|
|Listed as ongoing, but also has a completion date||2020-001317-20||A Phase IIa, randomized, double-blind placebo-controlled, dose comparison, multi centre adaptive design clinical trial to evaluate the immune signature of the treatment with the Imotope™ IMCY-0098 and...||2017-08-15||bad-data|